Compare Stocks → the most reliable asset on earth is making a comeback (From DTI) (Ad) Compare stocks and their fundamentals, performance, price, and technicals. Use this free stock comparison tool to evaluate companies based on their analyst ratings, book value, debt, dividend, MarketRank, news sentiment, price performance, profitability, and more. Enter up to ten stock symbols separated by a comma or space (ex. BAC, JPM, WFC, C, GS). Comparison Ideas Agriculture StocksAirline StocksApparel StocksArtificial Intelligence StocksAutomotive StocksBank StocksBitcoin StocksBlockchain StocksCanadian StocksCannabis StocksCasino StocksChatGPT StocksChinese StocksCloud Storage StocksCoronavirus Therapeutics StocksCryptocurrency StocksCybersecurity StocksDefense StocksDividend StocksDow 30 StocksEcommerce StocksElectric Vehicles StocksEnergy StocksEntertainment StockseSports StocksEV Charging StocksFertilizer StocksGold StocksGrocery StocksGrowth StocksHealthcare StocksHigh Dividend StocksHome Office StocksHotel StocksLarge Cap StocksLeisure StocksLithium StocksMagnificent Seven StocksMATANA StocksMega Cap StocksMeme StocksMetaverse StocksMid Cap StocksMining StocksMusic Industry StocksNanotechnology StocksNFT StocksOil StocksOutdoor Activities StocksPharmaceutical StocksRenewable Energy StocksRestaurant StocksRetail StocksSemiconductor StocksSocial Media StocksSolar StocksSpace StocksStay-At-Home StocksTechnology StocksTelecom StocksToy StocksUtility StocksVaccine StocksVideo Game StocksVirtual Reality StocksWallStreetBets Stocks Stocks to Compare Sections All Sections Selected Performance Chart Price & Volume MarketRank Analyst Ratings Sales & Book Value Profitability & Earnings Dividends Debt Ownership Miscellaneous Headlines About Compare Share Comparison Share Comparison NASDAQ:BLUTSE:FGX Comparative Price Performance Over Time1 day7 days30 days90 days365 daysCompare Stocks - Price & VolumeCompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's VolumeBLUBELLUS Health$14.74$14.62$6.38▼$14.76$1.87B0.193.08 million shs3.45 million shsFGXFaircourt Gold IncomeC$2.60C$2.32▼C$3.58C$7.21MN/A5,795 shs2,500 shsBeginners Guide To Retirement StocksClick the link below and we'll send you MarketBeat's list of seven best retirement stocks and why they should be in your portfolio. Get This Free ReportPrice PerformanceCompany1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year PerformanceBLUBELLUS Health0.00%0.00%0.00%0.00%+106.44%FGXFaircourt Gold Income0.00%0.00%0.00%0.00%0.00%The Small Biotech with a BIG Cancer Solution (Ad)There's a new cancer treatment so precise, it's been called a "smart bomb." One that can deliver a toxic payload directly to tumors while bypassing healthy cells.Get the full story here >>>MarketRank™CompanyOverall ScoreAnalyst's OpinionShort Interest ScoreDividend StrengthESG ScoreNews and Social Media SentimentCompany OwnershipEarnings & ValuationBLUBELLUS Health0.0909 of 5 stars1.10.00.00.00.63.30.0FGXFaircourt Gold IncomeN/AN/AN/AN/AN/AN/AN/AN/AAnalyst RatingsCompanyConsensus Rating ScoreConsensus RatingConsensus Price Target% Upside from Current PriceBLUBELLUS Health2.25Hold$14.750.07% UpsideFGXFaircourt Gold IncomeN/AN/AN/AN/ACurrent Analyst RatingsSales & Book ValueCompanyAnnual RevenuePrice/SalesCashflowPrice/CashBook ValuePrice/BookBLUBELLUS Health$15K124,613.93N/AN/A$3.09 per share4.77FGXFaircourt Gold IncomeC$1.67M0.00N/A0.63C$3.59 per share0.00Profitability & EarningsCompanyNet IncomeEPSTrailing P/E RatioForward P/E RatioP/E GrowthNet MarginsReturn on Equity (ROE)Return on Assets (ROA)Next Earnings DateBLUBELLUS Health-$76.08M-$0.72N/AN/AN/A-578,586.63%-24.27%-23.14%N/AFGXFaircourt Gold IncomeN/AC$0.2112.56N/AN/AN/AN/AN/AN/ADividendsCompanyAnnual PayoutDividend Yield3-Year Dividend GrowthPayout RatioYears of Consecutive GrowthBLUBELLUS HealthN/AN/AN/AN/AN/AFGXFaircourt Gold IncomeC$0.29N/AN/A139.13%N/ADebtCompanyDebt-to-Equity RatioCurrent RatioQuick RatioBLUBELLUS HealthN/A33.4233.42FGXFaircourt Gold Income11.867.887.88OwnershipInstitutional OwnershipCompanyInstitutional OwnershipBLUBELLUS Health90.37%FGXFaircourt Gold IncomeN/AInsider OwnershipCompanyInsider OwnershipBLUBELLUS Health24.17%FGXFaircourt Gold IncomeN/AMiscellaneousCompanyEmployeesShares OutstandingFree FloatOptionableBLUBELLUS Health74126.81 million96.16 millionNot OptionableFGXFaircourt Gold IncomeN/A2.77 millionN/ANot OptionableKRM, FGX, EDGH, BLU, and TAVI HeadlinesSourceHeadlineFaircourt Asset Management Inc. Announces March Distributionfinance.yahoo.com - March 22 at 9:48 PMFaircourt Asset Management Inc. Announces February Distributionfinance.yahoo.com - February 23 at 8:11 PMFaircourt Asset Management Inc. Announces January Distributionfinance.yahoo.com - January 26 at 12:48 AMFaircourt Asset Management Inc. Announces December Distributionfinance.yahoo.com - December 20 at 8:40 PMFAIRCOURT SPLIT TRUST TO BE WOUND UPbenzinga.com - November 1 at 10:48 PMCBOE Gold Target Income Monthly (GLDTI)investing.com - October 11 at 12:27 AMFCS-UN.NE - FAIRCOURT SPLIT TRUST - UNITSca.finance.yahoo.com - August 16 at 2:13 AMDebt-to-Income Ratio Calculatornerdwallet.com - July 24 at 9:35 AMFaircourt Gold Income Corp. (FGX.TO)ca.finance.yahoo.com - May 2 at 8:36 AMFaircourt Asset Management Inc. Announces Februaryvietreader.com - February 23 at 9:19 PMGold's allure to dim in India on lower rural incometimesofindia.indiatimes.com - September 22 at 10:49 AMFaircourt Asset Management Inc. Announces July Distributionfinance.yahoo.com - July 25 at 8:29 PMCORRECTION: Faircourt Asset Management Inc. Announces Adjustment in Distribution for the Trust Units of Faircourt Split Trustfinance.yahoo.com - July 20 at 9:48 PMFaircourt Asset Management Inc. Announces Adjustment in Distribution for the Trust Units of Faircourt Split Trustfinance.yahoo.com - July 19 at 8:05 PMFaircourt Gold Income Corp (FGX)investing.com - December 3 at 9:36 PMNew MarketBeat Followers Over TimeMedia Sentiment Over TimeTop HeadlinesHow to Invest in Artificial Intelligence in These Simple WaysMarch 7, 2024 1:08 PMView How to Invest in Artificial Intelligence in These Simple Ways5 Under-the-Radar Artificial Intelligence (AI) Stocks March 4, 2024 9:30 AMView 5 Under-the-Radar Artificial Intelligence (AI) Stocks Your Comprehensive Guide to Investing in Bank StocksMarch 1, 2024 10:41 AMView Your Comprehensive Guide to Investing in Bank Stocksbluebird bio Stock Signals Potential to be a Multi-bagger February 29, 2024 9:55 AMView bluebird bio Stock Signals Potential to be a Multi-bagger Beam Therapeutics Bolts Higher on Gene Therapy Licensing PaymentsMarch 6, 2024 6:19 AMView Beam Therapeutics Bolts Higher on Gene Therapy Licensing PaymentsAll Headlines Company DescriptionsBELLUS HealthNASDAQ:BLUBELLUS Health Inc., a clinical-stage biopharmaceutical company, develops therapeutics for the treatment of refractory chronic cough (RCC) and other cough hypersensitivity indications. Its lead product candidate includes BLU-5937, an antagonist of the P2X3 receptor, which is in Phase II clinical trial for treatment of RCC and chronic pruritus. BELLUS Health Inc. was incorporated in 1993 and is based in Laval, Canada. As of June 28, 2023, BELLUS Health Inc. operates as a subsidiary of GSK plc.Faircourt Gold IncomeTSE:FGXFaircourt Gold Income Corp. is a closed-ended equity mutual fund launched and managed by Faircourt Asset Management Inc. It invests in the public equity markets of Canada. The fund seeks to invest in stocks of companies operating in the precious metals sector, with an emphasis on companies involved in gold mining and exploration. It primarily invests in stocks of senior and intermediate gold producers that are part of the S&P/TSX Global Gold Index. The fund benchmarks the performance of its portfolio against S&P/TSX Global Gold Index. Faircourt Gold Income Corp. was formed on November 16, 2007 and is domiciled in Canada. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Your Password: or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Choose a Password: Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.